Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development

by Scott Larrivee | Oct 17, 2024 | News

Image above: Starget Pharma, stargetpharma.com VALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a physics company transforming the production of radioisotopes, and Starget Pharma, a clinical-stage biotechnology company developing precision peptide...

Nusano to Present at Jefferies Radiopharma Innovation Summit

by Scott Larrivee | Apr 10, 2024 | News

VALENCIA, Calif. – April 10, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, today announced it will attend and present at Jefferies Radiopharma Innovation Summit in New York City on Thursday, April 11, 2024. In his presentation,...

Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event

by Scott Larrivee | Apr 20, 2023 | News

NEW YORK – April 20, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced its co-founder and Chief Operating Officer (COO), Dr. Howard Lewin, will take part in a virtual event hosted by Truist Securities on Friday,...

Welsh Government seeks to create ‘global centre of excellence in nuclear medicine’

by Scott Larrivee | Jan 11, 2023 | Industry News

Jan. 11, 2023 – Citing aging infrastructure and anticipated future demand, the Welsh government is taking action to establish a stable supply of medical radioisotopes for citizens of the United Kingdom. World Nuclear News reports: The Welsh government says that, as...